Cell Signaling Technology (United States)
Cell Signaling Technology, Inc. is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cell Signaling Technology (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
70%
Total
Publications
519
Total Open
Publications
362
Total
Citations
68K
Open Access
Percentage
70%
Total
Publications
519
Total Open
Publications
362
Total
Citations
68K
Breakdown
Publisher Open
20%
Both
35%
Other Platform Open
12%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
129
Hybrid 33%
88
No Guarantees 18%
48
Other Platform Open
Domain 67%
160
Other Internet 28%
66
Institution 19%
45
Public 6%
15
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 160 |
DOI | Other Internet | 62 |
DASH - Digital Access to Scholarship at Harvard | Institution | 18 |
Figshare | Public | 15 |
Europe PMC | Domain | 7 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 6 |
Unknown Repository | Other Internet | 5 |
University of Turin - Institutional Research Information System University of Turin | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Yonsei University Medical Library - YUHSpace | Institution | 2 |